Image

    Detection of Urine Metabolites in Polycystic Ovary Syndrome by UPLC Triple-TOF-MS

    June 2015 in “ Clinica Chimica Acta ”
    Wencui Wang, Shenglin Wang, S.G. Tan … Chao Yu
    Studysummary In this study, researchers identified two potential urinary biomarkers, testosterone–glucuronide and 11α-hydroxyprogesterone, along with four candidate biomarkers, to help understand and diagnose polycystic ovary syndrome.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on doi.org →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Metabolomic Biomarkers in Women with Polycystic Ovary Syndrome: A Pilot Study Molecular human reproduction · 2012
    2. Polycystic Ovary Syndrome: Dermatological Approach Anais Brasileiros De Dermatologia · 2011
    3. Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome Fertility and Sterility · 2004
    4. The Effect of the Antiandrogen 11α-Hydroxyprogesterone on Sebum Production and Cholesterol Concentration of Sebum British Journal of Dermatology · 1982